Last reviewed · How we verify

NCT05540379

Role of Virtual Reality Simulators in Basic Hysteroscopy Training Competence

Completed NA Last updated 14 September 2022
What this trial tests

NA trial testing Virtual Reality Training in Hysteroscopy in 102 participants. Completed in 30 April 2022.

Timeline
1 May 2021
Primary endpoint
1 April 2022
30 April 2022

Quick facts

Lead sponsorEgymedicalpedia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment102
Start date1 May 2021
Primary completion1 April 2022
Estimated completion30 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 26 to 36, any sex, with Hysteroscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation the efficacy of Virtual Reality simulator training in improving basic gynecological hysteroscopic skills and assess training levels in Ob/Gyn residents, as compared to others with previous hysteroscopic experience.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality Training

Trials testing the same drug.

Other recruiting trials for Hysteroscopy

Currently open trials in the same condition.

Other Egymedicalpedia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05540379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing